• Profile

Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post‐endoscopic retrograde cholangiopancreatography pancreatitis

Digestive Endoscopy Feb 08, 2022

In this study, adverse events (AEs) incidence was 10.1% in patients with intact papilla who underwent biliary endoscopic retrograde cholangiopancreatography (ERCP). Mortality was 0.08%, and post-ERCP pancreatitis (PEP) may be avoided by prophylactic pancreatic stenting (PPS) and epinephrine spraying.

  • This study included 16,032 ERCP procedures in 3,739 patients to assess the incidence and severity of AEs in biliary ERCP as well as to specify the risk factors and preventive measures for PEP.

  • The overall incidence of AEs was estimated to be 10.1% and ERCP-associated mortality was 0.08%.

  • PEP, bleeding, instrumental AEs, infections, cardiovascular AEs, pulmonary AEs, drug reaction AE, pain, and other AEs occurred in 6.9%, 0.9%, 0.5%, 1.0%, 0.2%, 0.2%, 0.03%, 0.4%, and 0.4% of cases respectively.

  • Female of younger age, pancreatic guidewire-assisted biliary cannulation, temporary guidewire insertion into the pancreatic duct, total procedure time >60 min, and post-ERCP use of non-steroidal anti-inflammatory drugs were the significant risk factors for PEP.

  • PPS and epinephrine spraying onto the papilla were effective as preventive measures.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen